CEREVEL THERAPEUTICS HLDNG I
CALL · CUSIP 15678U908
0
institutional holders
+0 vs Q1 2024
—reported value*
0 new
0 added
0 reduced
0 sold out
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Options: 5 managers hold calls ($60.7m notional), 0 hold puts (—).
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 0 |
| Q4 2022 | 0 |
| Q1 2023 | 0 |
| Q2 2023 | 0 |
| Q3 2023 | 0 |
| Q4 2023 | 0 |
| Q1 2024 | 0 |
| Q2 2024 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 0 | 0 |
| Q1 2023 | 0 | 0 |
| Q2 2023 | 0 | 0 |
| Q3 2023 | 0 | 0 |
| Q4 2023 | 0 | 0 |
| Q1 2024 | 0 | 0 |
| Q2 2024 | 0 | 0 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2023 | $7.6m | $0 | 0.00 |
| Q4 2023 | $25.5m | $0 | 0.00 |
| Q1 2024 | $21.0m | $0 | 0.00 |
| Q2 2024 | $60.7m | $0 | 0.00 |
Biggest calls
| Maven Securities LTD | New | $41.8m1.0m shares |
| JANE STREET GROUP, LLC | Reduced | $14.7m358.5k shares |
| GROUP ONE TRADING LLC | Reduced | $2.8m69.0k shares |
| SIMPLEX TRADING, LLC | Reduced | $1.4m33.6k shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Biggest puts
| None |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Holders, Q2 2024
| Manager | Shares | Change |
|---|